Pradeep Sharma, M.D. Anderson Chair Professor and department chair at the University of Houston, was named to the National Academy of Engineering. Photo via uh.edu

A national organization has named its latest cohort of new members — which includes Elon Musk — and five Houston-area innovators have also made the cut.

The National Academy of Engineering elected 111 new members and 22 international members, bringing the total U.S. membership to 2,388 and the number of international members to 310. The appointment is among the highest professional distinctions in an engineer's career. Each member has been found to have made significant contributions to "engineering research, practice, or education, including, where appropriate, significant contributions to the engineering literature," according to a news release.

The newly elected class will be formally inducted during the NAE's annual meeting on Oct. 2. The five Houston-area appointees and what they are being recognized for are:

  • Richard G. Baraniuk, C. Sidney Burrus Professor, Department of Electrical and Computer Engineering, Rice University. For the development and broad dissemination of open educational resources and for foundational contributions to compressive sensing.
  • Donald Nathan Meehan, president, CMG Petroleum Consulting Ltd.. For technical and business innovation in the application of horizontal well technology for oil and gas production.
  • Pradeep Sharma, M.D. Anderson Chair Professor and department chair, Department of Mechanical Engineering, University of Houston. For establishing the field of flexoelectricity, leading to the creation of novel materials and devices and insights in biophysical phenomena.
  • Leon Thomsen, chief scientist, Delta Geophysics Inc. For contributions to seismic anisotropy concepts that produced major advances in subsurface analysis.
  • David West, corporate fellow, Corporate Research and Innovation, Saudi Basic Industries Corp. For solutions to problems with technological, commercial, and societal impacts while advancing chemical sciences by applying reaction engineering fundamentals.

In a news release from UH, Sharma says it's the highest honor he could achieve as an engineer. The NAE recognized Sharma's work within flexoelectricity, a relatively understudied, exotic phenomenon that has the potential to provide similar functionality as piezoelectrics.

“Nature has provided us very few piezoelectric materials even though their applications in energy harvesting and in making sensors is very important. What we did was use theory to design materials that perform like piezoelectric ones, so that they can create electricity,” says Sharma in the release.

Sharma has worked at UH since 2004, and previously conducted research at General Electric for three years.

“The recognition of Professor Sharma by the National Academy of Engineering highlights a career full of outstanding research that has contributed to the understanding of engineering and helped uncover solutions for some of the world’s most significant problems,” says Paula Myrick Short, UH senior vice president for academic affairs and provost, in the release.

Over at Rice, Baraniuk's engineering career includes computational signal processing, most recently as it relates to machine learning. He's best known for spearheading the creation of Connexions, one of the first open-source education initiatives, and its successor, OpenStax, which publishes high-quality, peer-reviewed textbooks that are free to download.

“It’s auspicious timing that the NAE citation mentioned open education, because the seventh of February was the 10th anniversary of OpenStax publishing its first free and open textbook,” he says in a release from Rice. “It’s neat to have this happen in the same week, and worth pointing out that if ever there was a team effort, it was Connexions and OpenStax.”

Baraniuk has been at Rice since 1992, has three degrees in electrical and computer engineering.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.